Abstract P76  Table 1: appropriateness, success and contraindication rates for patients with and without proformas
Successfully weaned from NIVAppropriate for NIV trialNo of patients with contraindications started on NIV
Patients with proforma(n = 46)30 (65%)32 (70%)8 (17%)
Patients without proforma(n = 19)5 (26%)3 (21%)12 (63%)